Michael L Jones has sold BCRX and made no open-market buys since Mar 2022

Michael L. Jones is a corporate finance executive who served as Executive Director, Finance and Principal Accounting Officer at BioCryst Pharmaceuticals Inc. (BCRX), where he held responsibility for the company’s finance function and principal accounting oversight.( He was formally appointed to this role by BioCryst’s board and has been identified in regulatory and insider trading disclosures as Exec. Director, Finance – PAO, reflecting his position as a key corporate insider with share ownership in the company.(

In July 2023, Jones notified BioCryst of his intention to resign, and the company announced that he would continue as Executive Director, Finance through April 2024 to support the transition of his duties; his departure was explicitly noted as not resulting from any disagreement over BioCryst’s operations, policies, or practices.( Public filings and market data describe him solely as an individual officer of BioCryst rather than a separate corporate entity, confirming that Jones Michael L is a person (individual) corporate insider.(

Written by Perplexity from public sources.